Atlas Trials

The Study to YD312 Tablet in Patients With Diabetic Macular Edema

Clinical trial NCT03635814 · UNKNOWN

Trial details

NCT number
NCT03635814
Sponsor
YD Global Life Science Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Macular Edema(DME)
Start date
2017-10-19
Primary completion
2018-07-27
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.